← back to search

Döst Öngür

Harvard University · US
Area of research
Psychiatry and Mental health · Cognitive Neuroscience
Research interest
Research interests include Schizophrenia research and treatment, Functional Brain Connectivity Studies, Bipolar Disorder and Treatment, and Advanced MRI Techniques and Applications.
h-index
76
citations
37,800
works
527
NIH funding
primary concept
Medicine
email

Recent publications

Brain and body energy metabolism and potential for treatment of psychiatric disorders
Nature Mental Health 2025cited by 15position: middledoi
Comparative Effectiveness of Long-Acting Injectable Vs. Oral Antipsychotic Medication After a First Episode of Psychosis: A Target Trial Emulation
Biological Psychiatry 2025cited by 0position: middledoi
Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions
World Psychiatry 2024cited by 64position: middledoi
Towards a youth mental health paradigm: a perspective and roadmap
Molecular Psychiatry 2023cited by 274position: middledoi
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis
Molecular Psychiatry 2023cited by 73position: middledoi
A preliminary choroid plexus volumetric study in individuals with psychosis
Human Brain Mapping 2023cited by 46position: middledoi
579. Benchmarking Observational Analyses Against Randomized Trial Results: An Application to First Episode Psychosis
Biological Psychiatry 2023cited by 0position: middledoi
Rare coding variants in ten genes confer substantial risk for schizophrenia
Nature 2022cited by 863position: middledoi
Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia
Molecular Psychiatry 2022cited by 61position: middledoi
Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer’s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies
Ageing Research Reviews 2021cited by 309position: middledoi
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level
JAMA Psychiatry 2021cited by 144position: middledoi
Reduced adaptation of glutamatergic stress response is associated with pessimistic expectations in depression
Nature Communications 2021cited by 35position: middledoi
Transdiagnostic clinical staging in youth mental health: a first international consensus statement
World Psychiatry 2020cited by 282position: middledoi
Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell–derived cortical interneurons from subjects with schizophrenia
Nature Neuroscience 2019cited by 121position: middledoi
Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene
Biological Psychiatry 2019cited by 44position: middledoi
The human cortex possesses a reconfigurable dynamic network architecture that is disrupted in psychosis
Nature Communications 2018cited by 96position: middledoi
Auditory steady state response deficits are associated with symptom severity and poor functioning in patients with psychotic disorder
Schizophrenia Research 2018cited by 72position: middledoi
Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis
Molecular Psychiatry 2018cited by 63position: lastdoi
Regional GABA Concentrations Modulate Inter-network Resting-state Functional Connectivity
Cerebral Cortex 2018cited by 62position: lastdoi
Using Dual Regression to Investigate Network Shape and Amplitude in Functional Connectivity Analyses
Frontiers in Neuroscience 2017cited by 466position: middledoi
Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons
Molecular Psychiatry 2014cited by 169position: middledoi
The Human Ortholog of Acid-Sensing Ion Channel Gene ASIC1a Is Associated With Panic Disorder and Amygdala Structure and Function
Biological Psychiatry 2014cited by 80position: middledoi
Disruption of Cortical Association Networks in Schizophrenia and Psychotic Bipolar Disorder
JAMA Psychiatry 2013cited by 457position: lastdoi
In Vivo Evidence for Cerebral Bioenergetic Abnormalities in Schizophrenia Measured Using<sup>31</sup>P Magnetization Transfer Spectroscopy
JAMA Psychiatry 2013cited by 135position: lastdoi
Brain gamma‐aminobutyric acid (<scp>GABA</scp>) abnormalities in bipolar disorder
Bipolar Disorders 2013cited by 104position: lastdoi
A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder
Translational Psychiatry 2012cited by 72position: lastdoi
Gray matter volume in schizophrenia and bipolar disorder with psychotic features
Schizophrenia Research 2012cited by 50position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Bruce M. Cohen · Butler Hospital6 papers (2012–2018)Fei Du · Fudan University4 papers (2013–2021) · 3 papers (2012–2025)Perry F. Renshaw · Huntsman (United States)3 papers (2012–2013)Justin T. Baker · Hospital for Sick Children3 papers (2012–2018) · 2 papers (2014–2018)Jordan W. Smoller · Broad Institute2 papers (2014–2018) · 2 papers (2013–2013)Randy L. Buckner · Harvard University2 papers (2013–2014) · 2 papers (2023–2025)Maria Ferrara · University of Ferrara2 papers (2023–2025) · 2 papers (2013–2021)Roscoe O. Brady · Beth Israel Deaconess Medical Center2 papers (2012–2013)Diego A. Pizzagalli · Boston Medical Center2 papers (2018–2021)Miguel A. Hernán · Harvard University2 papers (2023–2025)Deepak K. Sarpal · Northwell Health2 papers (2024–2025)Matcheri S. Keshavan · Harvard University2 papers (2012–2020) · 2 papers (2023–2025)Gonzalo Martínez‐Alés · Columbia University2 papers (2023–2025)B.T. Thomas Yeo · University of Tsukuba2 papers (2013–2018)